Spoken Alpha
Verano Holdings Corp.
Verano Holdings Corp. operates licensed cannabis cultivation, processing, wholesale distribution, and retail facilities across 13 U.S. states. The company vertically integrates seed-to-sale operations, producing cannabis products under brands including Encore, Avexia, and MÜV, and operates 160 retail dispensaries under the Zen Leaf and MÜV banners.
Verano Holdings Corp is a Healthcare company operating in Drug Manufacturers - Specialty & Generic with a $443.7M market cap.
VRNO beat consensus EPS by 1.0% in Q2 FY2026, reported Aug 4, 2026.
Behavioral analysis
Disclosures
Extracted from SEC 10-K filing, 2026-08-30.
Transcripts
We index calls for roughly 3,000 US-listed companies. If you'd like us to add VRNO, reply to your welcome email and we'll prioritize it.
History
Executives who appear on this company's earnings calls in our corpus, with role and tenure sourced from SEC filings. Click any name for the full role timeline and call appearance history. Per-executive behavioral deviation metrics are available to research subscribers.
Peers
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for VRNO.
$ curl https://api.spokenalpha.com/v1/companies/VRNOFAQ
Spoken Alpha indexes VRNO's earnings call transcripts at https://spokenalpha.com/companies/VRNO. Each call links to attributed speakers and parsed analyst Q&A. Verano Holdings Corp.'s own investor relations page is at https://investors.verano.com/.
Verano Holdings Corp. (VRNO) operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q2 FY2026 | 2026-08-04 | $0.03 | $-0.30 | +100.0% | $217.9M | — | — | EODHD |
| Q1 FY2026 | 2026-04-29 | $-0.01 | $-0.30 | +96.7% | $208.2M | — | — | EODHD |
| Q4 FY2025 | 2025-12-30 | $0.01 | $-0.21 | +100.0% | $206.6M | — | — | EODHD |
| Q3 FY2025 | 2025-10-28 | $-0.30 | $-0.21 | -42.9% | — | — | — | EODHD |
| Q2 FY2025 | 2025-08-06 | $-0.29 | $-0.22 | -31.8% | $202.3M | — | — | EODHD |
| Q1 FY2025 | 2025-05-07 | $-0.03 | $-0.04 | +21.7% | $209.8M | — | — | EODHD |
| Q4 FY2024 | 2025-02-26 | $0.18 | $-0.36 | +100.0% | $218.2M | — | — | EODHD |
| Q3 FY2024 | 2024-11-06 | $-0.55 | $-0.20 | -100.0% | $216.7M | — | — | EODHD |
| Q2 FY2024 | 2024-08-06 | $-0.16 | $-0.20 | +20.0% | $222.4M | — | — | EODHD |
| Q1 FY2024 | 2024-05-07 | $0.01 | $-0.24 | +100.0% | — | — | — | EODHD |
| Q4 FY2023 | 2024-02-28 | $-0.21 | $-0.21 | -0.4% | — | — | — | EODHD |
| Q3 FY2023 | 2023-11-07 | $-0.15 | $-0.16 | +6.3% | — | — | — | EODHD |
| Q2 FY2023 | 2023-08-07 | $-0.14 | $-0.14 | 0.0% | — | — | — | EODHD |
| Q1 FY2023 | 2023-05-09 | $-0.13 | $-0.13 | 0.0% | — | — | — | EODHD |
| Q4 FY2022 | 2023-03-29 | $-0.64 | $-0.60 | -5.8% | — | — | — | EODHD |
| Q3 FY2022 | 2022-11-13 | $-0.68 | $-0.22 | -100.0% | — | — | — | EODHD |
| Q2 FY2022 | 2022-08-15 | $0.06 | $-0.02 | +100.0% | — | — | — | EODHD |
| Q1 FY2022 | 2022-05-24 | $-0.50 | $0.21 | -100.0% | — | — | — | EODHD |
| Q3 FY2021 | 2021-11-15 | $0.82 | $0.50 | +64.0% | — | — | — | EODHD |
| Q2 FY2021 | 2021-08-09 | $0.36 | $0.63 | -42.9% | — | — | — | EODHD |
Source: EODHD. VRNO reported actuals as published; sparse fields render as —.